Phenibut – the Russian anti-anxiety drug linked to Gold Coast teens’ overdoses

Dr Janet Cheung

writer

Dr Janet Cheung

Lecturer in Pharmacy, University of Sydney

Dr Jonathan Penm

writer

Dr Jonathan Penm

Lecturer (Pharmacy), University of Sydney

Phenibut was initially developed in the 1960s in Russia as an anti-anxiety (anxiolytic) drug with cognitive enhancing properties. It has since attracted a strong following of users in the “smart drug” market, with claims of boosting memory recall and exam performance.

Originally given to Soviet cosmonauts to combat anxiety and insomnia, the powdered drug is suspected to have played a role in the recent overdose of seven teenagers at a Queensland private school.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone AM

Prof Andrew Sindone AM

MRAs for Heart Failure Update - New Developments

Prof David Price

Prof David Price

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

A/Prof Ralph Audehm & Prof Simone Strasser

A/Prof Ralph Audehm & Prof Simone Strasser

Abnormal LFTs – Practical Cases Expert Q&A

Angela Newbound

Angela Newbound

Practical Strategies to Increase Vaccination Rates This Flu Season

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Janet Cheung

writer

Dr Janet Cheung

Lecturer in Pharmacy, University of Sydney

Dr Jonathan Penm

writer

Dr Jonathan Penm

Lecturer (Pharmacy), University of Sydney

Test your knowledge

Recent articles

Latest GP poll

Mark Butler says 50% of practices are now bulk billing. To what extent does this match with your observation within the profession?

Overestimated

0%

Accurate

0%

Technically accurate but misleading

0%

Underestimated

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.